Document Detail


Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
MedLine Citation:
PMID:  11891606     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Endothelin (ET) is a broncho- and vasoconstrictive cytokine, but it also possesses proinflammatory and mitogenic activity. It is suggested to be involved in the pathogenesis of fibrotic lung diseases. We analyzed the concentration of ET 1 in the bronchoalveolar lavage (BAL) fluid in 95 patients with different lung diseases, among them 41 patients with interstitial lung diseases (13 fibrosing alveolitis in systemic sclerosis (FASS), 9 idiopathic pulmonary fibrosis (IFP), 8 sarcoidosis (S), 6 occupational lung disease (OLD), 5 other alveolitidies A), 27 patients with pneumonia, and 8 patients with chronic obstructive pulmonary disease (COPD). A heterogeneous group of 19 patients served as controls. The median ET concentration was 3.3 pg/ml. Significantly higher concentration was found in patients with FASS (5.8 pg/ml), IPF (5.0 pg/ml), and S (5.1 pg/ml) compared with OLD (2.8 pg/ml), A (1.9 pg/ml), COPD (1.5 pg/ml), and the control group (2.5 pg/ml). In pneumonia, the elevated ET concentration (4.1 pg/ml) was accompanied by a high alveolocapillary leakage. When normalized to BAL albumin concentration, only FASS presented with significantly elevated ET/albumin in the BAL compared with the control group (134.5 vs. 56.l pg/mg, p < 0.05). There were no correlations between ET and BAL differential cell count or pulmonary function tests. In current smokers, ET in BALF was significantly higher compared with non- or ex-smokers (3.9 vs. 2.0 pg/ml, p < 0.01), but not so the ET/albumin ratio (65.0 vs. 62.5 pg/mg). In summary, ET in the BAL is differentially expressed in distinct inflammatory and interstitial lung disease. Consistently high concentrations are found in FASS and elevated ET concentration could be discussed in IPF, sarcoidosis, and pneumonia. ET concentration in BAL is influenced by current smoking habits.
Authors:
F Reichenberger; J Schauer; K Kellner; U Sack; P Stiehl; J Winkler
Related Documents :
18556626 - Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients ...
19440066 - Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute ...
9613386 - Platelet derived growth factor and fibroblast growth factor basic levels in the vitreou...
16442356 - Usefulness of biomarkers for predicting long-term mortality in patients with diabetes m...
16026376 - Coeliac disease in children with type 1 diabetes mellitus: the effect of the gluten-fre...
9654226 - Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrill...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2002-02-04
Journal Detail:
Title:  Lung     Volume:  179     ISSN:  0341-2040     ISO Abbreviation:  Lung     Publication Date:  2001  
Date Detail:
Created Date:  2002-03-13     Completed Date:  2002-04-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7701875     Medline TA:  Lung     Country:  United States    
Other Details:
Languages:  eng     Pagination:  163-74     Citation Subset:  IM    
Affiliation:
Division of Pneumology, Department of Internal Medicine, University Hospital, Johannisalle 32, 04105 Leipzig, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Albumins / analysis
Biological Markers / analysis
Bronchoalveolar Lavage Fluid / chemistry*,  cytology*
Endothelins / biosynthesis*
Female
Germany / epidemiology
Humans
Lung Diseases / etiology,  metabolism*
Male
Middle Aged
Prospective Studies
Pulmonary Fibrosis / etiology
Respiratory Function Tests
Smoking / adverse effects
Chemical
Reg. No./Substance:
0/Albumins; 0/Biological Markers; 0/Endothelins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Kv channel subunit expression in rat pulmonary arteries.
Next Document:  Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.